The corrected release reads:
ALCOHOLIC HEPATITIS TREATMENT MARKET WORTH USD 570 MILLION, AT 6% CAGR DURING 2019-2023 | TECHNAVIO
According to Technavio Research Report “Alcoholic Hepatitis Treatment Market by type (corticosteroids, xanthine derivatives, and others), and geographic regions (North America, Europe, Asia, and ROW) is witnessed to grow by USD 570 million, at a CAGR of 6% from 2019 to 2023”.
Free sample report contains market size and forecast, drivers, challenges, trends, and more – Request for Sample @
Global Alcoholic Hepatitis Treatment Market: Development of novel targets and viable treatment options for management of alcoholic hepatitis
Currently, there are no effective treatments for severe alcoholic hepatitis, which has led to a huge unmet need for effective treatment options in the market. This provides a huge opportunity for vendors in the market to develop novel targets and viable treatment options for management of alcoholic hepatitis. For instance, canakinumab, a monoclonal antibody inhibitor of interleukin-1, is being tested in Phase II clinical trials to treat alcoholic hepatitis. Thus, the development of novel treatment options will drive the alcoholic hepatitis treatment market growth during the forecast period.
“Apart from the development of novel targets and viable treatment options for management of alcoholic hepatitis, other factors such as the research for development of drugs that act against alcohol dependence, and the development of combination therapies to treat severe alcoholic hepatitis will have a significant impact on the growth of the alcoholic hepatitis treatment market size during the forecast period,” says a senior analyst at Technavio.
Global Alcoholic Hepatitis Treatment Market: Segmentation analysis
This market research report segments the global alcoholic hepatitis treatment market by type (corticosteroids, xanthine derivatives, and others), and geographic regions (North America, Europe, Asia, and ROW).
The North American region led the alcoholic hepatitis treatment market in 2018, followed by Europe, Asia, and ROW respectively. The alcoholic hepatitis treatment market in North America is led by the US and is driven by the increasing consumption of alcohol, which results in high mortality and morbidity rates. The development of drugs for treating alcoholic hepatitis is also expected to accelerate the market growth during the forecast period.
Speak to Research Expert @
Global Alcoholic Hepatitis Treatment Market: Increase in the consumption of alcohol worldwide
The excessive consumption of alcohol forms an acute inflammation in the liver, which is a major cause of alcoholic hepatitis. This has promoted the development of prognostic models that are useful in both prognostic stratification and selection of patients for appropriate therapy for the treatment of alcoholic hepatitis. Therefore, the growing consumption of alcohol is expected to fuel the growth of the alcoholic hepatitis treatment market during the next five years.
Few Major Players for the Alcoholic Hepatitis Treatment Market are:
- Apotex Inc.
- Gilead Sciences Inc.
- Johnson & Johnson Services Inc.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
Browse Industries Reports @ Pharmaceuticals
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at [email protected].
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200